EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Silencing of SLC6A1 Enhanced Cell Apoptosis in Prostate Cancer Through a Mitochondrial Mechanism

Chaojiang Chen, Ranting Wang, Zhuoyuan Lin, Jianxin Li, Yu Zheng

Advances in Urology · 2026-01 · 2026 (1)

DOI: 10.1155/aiu/7448726 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Urology, online erschienen am 15.04.2026. Verfasst von Chaojiang Chen und 4 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The present study aims to elucidate the molecular mechanisms underlying the association between solute carrier family 6 member 1 (SLC6A1) and the aggressive progression of prostate cancer, with a particular emphasis on its relationship with mitochondrial function.

Methods

To evaluate mitochondrial function, we detected mitochondrial membrane potential, adenosine triphosphate (ATP) production, intracellular reactive oxygen species (ROS) levels, and mitochondrial morphology in prostate cancer cell lines. Western blot was used to detect apoptosis‐related proteins. Gene set enrichment analysis (GSEA) was performed using The Cancer Genome Atlas (TCGA) prostate cancer dataset.

Results

Our findings indicated that silencing of SLC6A1 decreased mitochondrial membrane potential and ATP production while increasing intracellular ROS levels, accompanied by Bax upregulation and activation of the caspase pathway. Furthermore, GSEA results suggested that low SLC6A1 expression might trigger cell apoptosis via mitochondrial disruption mediated by the interaction between potassium and calcium channels.

Conclusion

These results highlighted the role of SLC6A1 in mitochondrial dysfunction associated with cell apoptosis in prostate cancer cells. This study has provided further insights into the molecular mechanisms of advanced prostate cancer and potential therapeutic targets.

Zitieren

APA

Chen, C., Wang, R., Lin, Z., Li, J., & Zheng, Y. (2026). Silencing of SLC6A1 Enhanced Cell Apoptosis in Prostate Cancer Through a Mitochondrial Mechanism. Advances in Urology, 2026(1). https://doi.org/10.1155/aiu/7448726

Vancouver

Chen C, Wang R, Lin Z, Li J, Zheng Y. Silencing of SLC6A1 Enhanced Cell Apoptosis in Prostate Cancer Through a Mitochondrial Mechanism. Advances in Urology. 2026;2026(1). doi:10.1155/aiu/7448726

BibTeX
@article{Chen2026,
  author = {Chen, Chaojiang and Wang, Ranting and Lin, Zhuoyuan and Li, Jianxin and Zheng, Yu},
  title = {Silencing of SLC6A1 Enhanced Cell Apoptosis in Prostate Cancer Through a Mitochondrial Mechanism},
  journal = {Advances in Urology},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/aiu/7448726}
}
Kostenlos starten →